Managing comorbidities in COPD

G Hillas, F Perlikos, I Tsiligianni… - International journal of …, 2015 - Taylor & Francis
Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality
worldwide. Age and smoking are common risk factors for COPD and other illnesses, often …

The economic burden of chronic obstructive pulmonary disease (COPD) in the USA, Europe, and Asia: results from a systematic review of the literature

A ur Rehman, MA Ahmad Hassali… - Expert review of …, 2020 - Taylor & Francis
Background: Lack of information about economic burden of COPD is a major cause of lack
of attention to this chronic condition from governments and policymakers. Objective: To find …

[HTML][HTML] Economic burden of COPD in the presence of comorbidities

DM Mannino, K Higuchi, TC Yu, H Zhou, Y Li, H Tian… - Chest, 2015 - Elsevier
BACKGROUND The morbidity and mortality associated with COPD exacts a considerable
economic burden. Comorbidities in COPD are associated with poor health outcomes and …

Acute exacerbation of COPD: is it the “stroke of the lungs”?

G Hillas, F Perlikos, N Tzanakis - International journal of chronic …, 2016 - Taylor & Francis
Chronic obstructive pulmonary disease (COPD) is one of the top five major causes of
morbidity and mortality worldwide. Despite worldwide health care efforts, costs, and medical …

COPD management costs according to the frequency of COPD exacerbations in UK primary care

YS Punekar, A Shukla, H Müllerova - International journal of …, 2014 - Taylor & Francis
Background The economic burden of chronic obstructive pulmonary disease (COPD)
exacerbations is significant, but the impact of other sources on the overall cost of COPD …

Systematic review of humanistic and economic burden of symptomatic chronic obstructive pulmonary disease

K Srivastava, D Thakur, S Sharma, YS Punekar - Pharmacoeconomics, 2015 - Springer
Background An understanding of the humanistic and economic burden of individuals with
symptomatic chronic obstructive pulmonary disease (COPD) is required to inform payers …

Standardisation of clinical assessment, management and follow-up of acute hospitalised exacerbation of COPD: a Europe-wide consensus

S Ramakrishnan, W Janssens, PR Burgel… - … journal of chronic …, 2021 - Taylor & Francis
Background Despite hospitalization for exacerbation being a high-risk event for morbidity
and mortality, there is little consensus globally regarding the assessment and management …

[HTML][HTML] Trends in hospital admissions for acute exacerbation of COPD in Spain from 2006 to 2010

J de Miguel-Díez, R Jiménez-García… - Respiratory …, 2013 - Elsevier
Objective We aim to analyze changes in incidence, comorbidity profile, length of hospital
stay (LOHS), costs and in-hospital mortality (IHM) of patients hospitalized for acute …

Clinical factors and comorbidities affecting the cost of hospital-treated COPD

S Deniz, A Şengül, Y Aydemir… - … journal of chronic …, 2016 - Taylor & Francis
Purpose We aimed to assess the effects of comorbidities on COPD costs and to investigate
the relationship between comorbidities and clinical variables. Patients and methods All …

Factors contributing to hospitalization costs for patients with COPD in China: a retrospective analysis of medical record data

M Li, F Wang, R Chen, Z Liang, Y Zhou… - … journal of chronic …, 2018 - Taylor & Francis
Purpose Hospitalization brings considerable economic pressure on COPD patients in
China. A clear understanding of hospitalization costs for patients with COPD is warranted to …